Alcon had three patents in metaverse during Q1 2024. The patent filed by Alcon Inc in Q1 2024 enables the psychophysical evaluation of vitreous floaters by projecting patient stimulus images onto the patient’s retina, capturing images of the retina, deriving shadow images of floaters, generating observer stimulus images, and projecting them onto the retinas of an observer using a virtual reality display device. GlobalData’s report on Alcon gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Alcon had no grants in metaverse as a theme in Q1 2024.
Recent Patents
Application: Psychophysical evaluation of the effect of vitreous floaters (Patent ID: US20240016379A1)
The patent filed by Alcon Inc. describes a method and system for evaluating vitreous floaters through psychophysical assessment. The method involves projecting patient stimulus images onto the patient's retina, capturing images of the retina using a scanning laser ophthalmoscope, and deriving shadow images representing floaters. These shadow images are then used to generate observer stimulus images that are projected onto an observer's retinas using a virtual reality display device. The system includes a retinal imaging device, a display device, and a computing device that processes the captured images to create observer stimulus images for display.
The method and system outlined in the patent claims enable the characterization of floaters by identifying shaded regions in the patient's retinal images and generating observer stimulus images based on these shadow images. The patient stimulus images used during the evaluation process can include fixation targets, and the system can simulate eye movement while reading by displaying a series of patient stimulus images with fixation targets at different locations. Additionally, the observer stimulus images can be adjusted in size and brightness based on the properties of the display device, which is specified as a virtual reality display device in the claims. The system is designed to provide a comprehensive evaluation of vitreous floaters through a combination of patient and observer stimulus images derived from retinal imaging data.
To know more about GlobalData’s detailed insights on Alcon, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
